HQH News and Press, Tekla Healthcare Investors From 09/08/21

We’ve seen economic data in recent months moderate after record growth in the first half of 2021. In financials, the rise of many fintech companies and the growth of digital payments has really disrupted the traditional banking industry, creating new options for consumers. ...

The Tekla World Healthcare Fund is a sector-focused CEF investing primarily in stocks along with some exposure to debt securities. We note that the fund has underperformed sector benchmarks and comparable funds on a total return basis over the last several years. While the 8.1% di...

Last year, we were looking at distribution changes due to the COVID pandemic sell-off. CEFs distribute out most of their earnings as distributions, so they pay relatively higher yields. However, relatively higher yields mean that any downturn is likely to cause distribution cuts. ...

Falling growth does not mean the economy is contracting. It merely means that the rate of increase is slowing. How much it slows is something we can't know yet, but it is exactly what we've been expecting for months as we watched bond yields drop. One reason I think the current enviro...

Shares of Tekla Healthcare Investors (NYSE:HQH) traded at a new 52-week high today of $27.20. Approximately 51,000 shares have changed hands today, as compared to an average 30-day volume of 105,000 shares. Tekla Healthcare Investors share prices have moved between a 52-week high of $27....

The IHS Markit Global Sector PMI™ signalled sustained strong recovery for the global economy, led by the consumer services sector. Basic Materials sector output growth eased for a second straight month to land in the last position of the eight sector groups we track in the glob...

Tekla Healthcare Investors (NYSE:HQH) traded at a new 52-week high today of $26.85. So far today approximately 58,000 shares have been exchanged, as compared to an average 30-day volume of 104,000 shares. Over the past year, Tekla Healthcare Investors has traded in a range of $19.43 to $...

THQ has been moving higher throughout 2021, after an already great year for the fund in 2020. The sell-off last year was brief but it was even more brief for THQ shareholders as the fund snapped back aggressively. If the Delta variant of the COVID virus sends countries back into l...

BMEZ is a fund focused on the growth side of healthcare, with exposure to some private investments. Private investments can be quite lucrative as it is participating before public launches that can see shares rise spectacularly. On the other side of this large potential is a highe...

Closed-ends funds as a whole have become quite stretched in value, this isn't any different for HQH. HQH holds an overweight exposure to biotech in the healthcare space - as the biotech space has been cooling down so has HQH. If you are a current shareholder, I believe it still ma...